File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)

Article: Impact of a drug allergy education course for non-specialists: Findings from ADAPT—A randomized crossover trial

TitleImpact of a drug allergy education course for non-specialists: Findings from ADAPT—A randomized crossover trial
Authors
Keywordsclinical trial
drug allergy
education
multidisciplinary
non-allergist
Issue Date1-Jan-2024
PublisherWiley
Citation
Allergy, 2024 How to Cite?
AbstractBackground: The consequences of drug allergy remain a global health concern. Drug allergy is often a neglected topic and many non-specialists lack sufficient knowledge or confidence in evaluating or managing this common condition. Evidence-based interventions to better equip non-specialists to tackle drug allergy are needed. The aim of the study is to evaluate the effectiveness of an intensive educational course on drug allergy knowledge and practice of non-specialists. Methods: A randomized crossover trial (NCT06399601) was conducted among practicing physicians and nurses participating in an intensive drug allergy course—Advances in Drug Allergy & Penicillin Testing (ADAPT). Participants' baseline knowledge and self-reported practices were assessed with standardized questionnaires (scored from 0 to 100, with “satisfactory” defined as ≥60/100). Participants were randomized into two cohorts and attended ADAPT at different time points. Serial responses before and after the course were compared within and between cohorts. Results: Seventy participants (25 physicians, 45 nurses) randomized into two groups completed the course. Baseline drug allergy knowledge (58.0 ± 19.9) and self-reported practice (36.9 ± 24.3) were unsatisfactory among non-specialists, with significantly lower scores from nurses than physicians in both domains (knowledge: 49.0 ± 17.4 vs. 74.0 ± 12.7; practice: 32.1 ± 21.3 vs. 53.3 ± 23.1; all p < 0.001). Following completion of ADAPT, participants demonstrated significant improvements in knowledge (58.0 ± 19.9 vs. 77.7 ± 15.9, p < 0.001) and self-reported practice (36.9 ± 24.3 vs. 71.0 ± 20.2, p < 0.001). All participants (100%) and 99% of participants agreed that the course improved their clinical knowledge and practice, respectively. Conclusions: ADAPT, an intensive drug allergy educational course was effective in improving drug allergy knowledge and practice for non-specialists. Further longitudinal studies are required to evaluate long-term impact.
Persistent Identifierhttp://hdl.handle.net/10722/346282
ISSN
2023 Impact Factor: 12.6
2023 SCImago Journal Rankings: 3.073

 

DC FieldValueLanguage
dc.contributor.authorLucas, Michaela-
dc.contributor.authorMak, Hugo W.F.-
dc.contributor.authorLee, Jasmine T.Y.-
dc.contributor.authorKulkarni, Rishabh-
dc.contributor.authorChan, Sophia S.C.-
dc.contributor.authorLi, Philip H.-
dc.date.accessioned2024-09-13T00:30:11Z-
dc.date.available2024-09-13T00:30:11Z-
dc.date.issued2024-01-01-
dc.identifier.citationAllergy, 2024-
dc.identifier.issn0105-4538-
dc.identifier.urihttp://hdl.handle.net/10722/346282-
dc.description.abstractBackground: The consequences of drug allergy remain a global health concern. Drug allergy is often a neglected topic and many non-specialists lack sufficient knowledge or confidence in evaluating or managing this common condition. Evidence-based interventions to better equip non-specialists to tackle drug allergy are needed. The aim of the study is to evaluate the effectiveness of an intensive educational course on drug allergy knowledge and practice of non-specialists. Methods: A randomized crossover trial (NCT06399601) was conducted among practicing physicians and nurses participating in an intensive drug allergy course—Advances in Drug Allergy & Penicillin Testing (ADAPT). Participants' baseline knowledge and self-reported practices were assessed with standardized questionnaires (scored from 0 to 100, with “satisfactory” defined as ≥60/100). Participants were randomized into two cohorts and attended ADAPT at different time points. Serial responses before and after the course were compared within and between cohorts. Results: Seventy participants (25 physicians, 45 nurses) randomized into two groups completed the course. Baseline drug allergy knowledge (58.0 ± 19.9) and self-reported practice (36.9 ± 24.3) were unsatisfactory among non-specialists, with significantly lower scores from nurses than physicians in both domains (knowledge: 49.0 ± 17.4 vs. 74.0 ± 12.7; practice: 32.1 ± 21.3 vs. 53.3 ± 23.1; all p < 0.001). Following completion of ADAPT, participants demonstrated significant improvements in knowledge (58.0 ± 19.9 vs. 77.7 ± 15.9, p < 0.001) and self-reported practice (36.9 ± 24.3 vs. 71.0 ± 20.2, p < 0.001). All participants (100%) and 99% of participants agreed that the course improved their clinical knowledge and practice, respectively. Conclusions: ADAPT, an intensive drug allergy educational course was effective in improving drug allergy knowledge and practice for non-specialists. Further longitudinal studies are required to evaluate long-term impact.-
dc.languageeng-
dc.publisherWiley-
dc.relation.ispartofAllergy-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectclinical trial-
dc.subjectdrug allergy-
dc.subjecteducation-
dc.subjectmultidisciplinary-
dc.subjectnon-allergist-
dc.titleImpact of a drug allergy education course for non-specialists: Findings from ADAPT—A randomized crossover trial-
dc.typeArticle-
dc.identifier.doi10.1111/all.16270-
dc.identifier.scopuseid_2-s2.0-85200479165-
dc.identifier.eissn1398-9995-
dc.identifier.issnl0105-4538-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats